Background. The 2009 influenza A pandemic virus (H1N1 pdm ) may reassort with old seasonal influenza A virus (H1N1 141 ) in humans and potentially change their pathogenicity.
Background. The 2009 influenza A pandemic virus (H1N1 pdm ) may reassort with old seasonal influenza A virus (H1N1 141 ) in humans and potentially change their pathogenicity.
Methods and Results. This study focuses on the reassortment of ribonucleoproteins (RNPs) among H1N1 pdm and seasonal influenza A viruses. A single RNP gene reassortment altered reporter gene expression levels driven by polymerase complex in transfection system. The growth rates of recombinant viruses with different RNP recombinations were changed in A549 cells. Mice were infected with recombinant viruses containing single RNP gene reassortment, and pathogenicity was examined. The results demonstrated that the median lethal dose (LD 50 ) of the PB2 141 /PB1 141 /PA pdm /NP 141 recombinant virus was lower than that of the seasonal H1N1 virus. Viral titers of this reassorted virus in the lung and spleen were significantly higher than that in seasonal H1N1 viruschallenged mice.
Conclusions. Although the changes of RNP activity did not exactly reflect to mice virulence, we consistently observed that the PA gene of H1N1 pdm results in increased polymerase activity, better replication in mice, and lower LD 50 . Our findings suggest that monitoring of gene reassortment for the 2009 pandemic influenza and seasonal human viruses is also important, which would help to constrain the potential emergence of a more virulent influenza A variant.
The genome of the influenza virus consists of 8 singlestranded negative-sense RNAs encoding 11 proteins [1, 2] . Influenza A viruses are major pathogens that have considerable impact on human health during yearly epidemics. They have caused high morbidity and mortality during the pandemics that occurred in 1918, 1957, 1968, and 2009 . Wild aquatic birds are the main reservoir for all subtypes of influenza A viruses and are the source for transmission to other animal species such as swine, horses, and humans [2] . Generally, avian influenza viruses cannot replicate efficiently or cause disease in humans. Most transmissions of avian influenza viruses from birds to humans do not result in circulation in the human population. However, adaptation to humans may occur and cause an influenza pandemic followed by the establishment of a new lineage of human influenza viruses. This may be what occurred in the 1918 virus, though the origin of this virus is still controversial [3] . Reassortment is an important mechanism of viral gene segment rearrangement in a host cell infected with 2 or more different viruses [2] . Reassortment can generate novel influenza strains that can cause an influenza pandemic [4] . Swine infected with avian influenza A subtype H5N1 have been identified in Vietnam [5] , and several reports indicated that swine influenza virus infections have occurred in humans [6] [7] [8] [9] . These may raise the possibility that swine could act as the ''mixing vessel'' that allows avian influenza virus to reassort with a human influenza strain, resulting in a virus with high pathogenicity and a high potential for human-to-human transmission. Reassortants that derive their gene segments from human and avian viruses can threaten humans, as they did in the 1957 and 1968 pandemics [10] .
In early April 2009, a new H1N1 swine-origin influenza A virus emerged in Mexico and the United States. It spread to more than 214 countries, with more than 18,449 mortalities reported [11] . The 2009 pandemic H1N1 virus (H1N1 pdm ) contains a unique combination of gene segments from swine, avian, and human viruses and was first identified from humans in 2009 [12] [13] [14] [15] . Like other influenza A viruses, this pandemic H1N1 may reassort with the coinfected influenza A virus and, therefore, exhibit a change in virulence. Any reassortment that alters the virulence of the parental strains would cause concern. In a ferret model, the 2009 pandemic H1N1 virus became more pathogenic than the seasonal H1N1 virus. The H1N1 pdm replicated better in the lower respiratory tract of animals than the seasonal influenza virus [16, 17] . The ribonucleoprotein (RNP) complex of the influenza virus, which is composed of PB2, PB1, PA, and NP genes, is a basic unit for virus replication and transcription, and the RNP complex has been considered as a major determinant of viral tropism [18, 19] . When reassortment occurs between the gene segments of RNP derived from H1N1 pdm and seasonal influenza virus, the characteristics of virus replication may change and further alter the pathogenicity and virulence of these reassortant viruses. For example, PB2 has been considered as a genetic factor that is associated with host restriction [18] [19] [20] . Boosted virulence has been reported when an avian influenza virus H5N1 acquired the PB2 gene segment from the human H3N2 virus [21] .
In this study, 
MATERIALS AND METHODS

Cells and Viruses
Madin-Darby canine kidney (MDCK) cells, 293T human embryonic kidney cells, A549 adenocarcinomic human alveolar basal epithelial cells, and DF-1 chicken fibroblast cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco). All cells were maintained at 37°C under conditions of 5% CO 2 . The RNP genes of influenza A viruses used in this study were from H1N1 seasonal influenza A virus, A/Taiwan/ 141/2002 (H1N1), as well as the pandemic H1N1, A/Taiwan/ 126/2009. Both of these viruses were isolated in Chang Gung Memorial Hospital and used for plasmid construction.
Molecular Cloning of Plasmids
Viral genomic RNA was extracted using an RNeasy kit (Qiagen). Full-length cDNAs were prepared by reverse transcription of the viral RNA using a primer complementary to the 12 bp conversed at the 3# end of each viral segment. Reverse transcriptase with incubation at 42°C for 1 hour was followed by incubation at 65°C for 15 minutes. Amplification was performed with segmentspecific primers. The polymerase chain reaction (PCR) products were digested with different restriction enzymes designated specifically for each gene segment and cloned into the plasmid pHW2000. Constructed cDNAs encoded the PB2, PB1, PA, and NP genes of the 3 viruses.
Chloramphenicol Acetyl Transferase Assay for Viral Polymerase Activities RNP activity was measured using a chloramphenicol acetyl transferase (CAT) enzyme-linked immunosorbent assay (ELISA). Different combinations of PB2, PB1, PA, and NP protein expression plasmids, and the pPolI-CAT-RT plasmid, were cotransfected into 293T cells. Cells were incubated at 37°C in DMEM containing 10% FBS. At 48 hours post transfection, cell extracts were prepared in a 250 lL lysis buffer and detected for CAT expression levels using a CAT ELISA kit (Roche), which allowed detection of 0.05 ng/mL CAT. All experiments were performed in triplicate.
Generation of Recombinant Viruses by Reverse Genetics
Recombinant viruses were generated using the 8-plasmid-based reverse genetic system described by Hoffmann et al. [22, 23] . Plasmids of A/PR8/34 strains were obtained from Robert G. an infectious dose high enough for animal study, the recombinant viruses were amplified in MDCK cells for 1-3 passages. The viral stocks were sequenced again before animal study.
Plaque Assay
Confluent MDCK cells in 35-mm dishes were washed with phosphate-buffered saline, and serial dilutions of the virus were then adsorbed onto cells for 1 hour at 37°C. Any unadsorbed virus was removed by washing with phosphate-buffered saline. The cells were then overlaid with 3 mL of overlay DMEM supplemented with 3% agarose. After incubation for 48 hours at 37°C, the cells were fixed with 10% formalin for 1 hour. Following formalin removal, the cells were stained with crystal violet and the plaques were visualized. Visible plaques were counted, and concentrations of plaque-forming unit (PFU)/mL were determined. The plaque numbers and sizes were obtained from at least 3 independent experiments.
Infection of Mice
To determine the dose lethal for 50% of mice (LD 50 ), recombinant viruses were serially 10-fold-diluted in PBS and intranasally inoculated into 6-week-old female BALB/c mice. Each group included 6 mice that were anesthetized by intraperitoneal injection with 0.12 mL of 0.3 mg tiletamine chlorhydrate and 0.3 mg zolazepam chlorhydrate (Zoletil; Virbac, Carros, France) and inoculated intranasally with 50 lL recombinant viruses. The infected mice were weighed and observed daily for illness or death. Mice that were found to be moribund were considered to have died on that day. The LD 50 was calculated by the ReedMuench method.
Pathogenicity Test in Mice
Eight-week-old female C57BL/6 mice purchased from BioLasco (Taiwan) were used in this study. All of these mice were maintained in accordance with the guidelines of the Institutional Animal Care and User Committee of Chang Gung University.
Three to 7 mice per group were intranasally infected with 200 PFU of viruses in 20 lL PBS. For the control group, 20 lL PBS was used. The mice were sacrificed on day 3 post infection, and the right lobe of the lung was removed and fixed in a 10% formalin solution for 24 hours. The lung sections were stained with hematoxylin and eosin (H&E) for immunopathologic evaluation. The lung, spleen, and liver were harvested on day 3 post infection. The homogenized tissues used for viral titrations were kept at -80°C. Plaque assays in MDCK cells detected virus titers of homogenates.
RESULTS
A Single RNP Gene Reassortment Altered Reporter Gene Expression Levels Driven by Polymerase Complex
To understand the effect of RNP gene reassortment on viral polymerase activity, an RNP functional assay was performed. Expression plasmids for PB2, PB1, PA, and NP were cotransfected with a plasmid that expressed a viral-like reporter RNA (pPolI-CAT-RT plasmid) [24] into 293T cells. The CAT protein expression levels were measured by ELISA. First, seasonal H1N1 RNP was used as a backbone, and each individual RNP gene segment was replaced with genes derived from H1N1 pdm (as illustrated in Figure 1A ), and the polymerase activity of these different combination was measured. Figure 1A shows that when the PB2 of seasonal H1N1 influenza viruses was replaced by that of H1N1 pdm , RNP activity decreased to 13%. When the PB1 of seasonal H1N1 influenza viruses was replaced, the CAT activity increased by approximately 7-fold, compared with that of all RNP segments originating from seasonal influenza viruses. On the other hand, PA from H1N1 pdm enhanced CAT activity by approximately 3-fold. When NP derived from the H1N1 pdm was introduced into the seasonal H1N1 backbone, CAT activity increased slightly (1.6-fold; Figure 1A ). H1N1 pdm RNP was then used as a backbone, and each gene segment from seasonal H1N1 was replaced. When the PB2 gene segment from seasonal H1N1 was introduced into the H1N1 pdm RNP backbone, polymerase activity was enhanced by 8-fold ( Figure 1B ). For other RNP gene segments (PB1, PA, and NP), the replacement either decreased or maintained the similar level of RNP activity ( Figure 1B ). Taken together, the results demonstrate that a single RNP gene replacement in the pandemic H1N1 and seasonal influenza viruses changes the RNP activities in the reporter gene expression assays.
Rescue and In Vitro Characterization of Recombinant Viruses
The RNP assay results indicate that single gene reassortment altered the reporter gene expression levels that were driven by polymerase activity. To determine whether this alteration would influence virus replication, recombinant viruses were generated by reverse genetics with different RNP gene combinations. The Biosafety Committee of the Center for Disease Control of Taiwan (CDC-Taiwan) did not allow any laboratory in Taiwan to generate mutant H1N1 pdm that had the potential to increase its virulence during the 2009 outbreak. Therefore, the genes for generating the recombinant virus, including HA, NA, M, and NS, were derived from a laboratory strain, PR8. The chimeric viruses, seasonal H1N1/PR8 and H1N1 pdm /PR8, were rescued ( Figure 2A ). After each RNP gene derived from H1N1 pdm was introduced into seasonal H1N1, the recombinant viruses were also rescued. According to the results of the RNP activities shown in Figure 1B , when the PB2 of seasonal H1N1 influenza viruses was introduced into the pandemic viral RNP, RNP activities were significantly enhanced. Therefore, this combination was also used for the generation of recombinant virus. The result showed that the virus was also rescued ( Figure 2A) . Next, the multicycle growth of these viruses in A549 cells was compared. As expected, the reassortant virus containing H1N1 pdm -PB2 grew significantly slower than the seasonal H1N1-RNP (derived from seasonal H1N1 virus)-containing virus. However, a lower growth rate of the PB2 141 /PB1 141 /PA 141 / NP pdm -containing virus in A549 cells was also observed, although this combination enhanced RNP activity slightly ( Figure 1A) . When H1N1 pdm -PB1 or -PA was introduced into a seasonal RNP-containing virus, there was no significant difference in the growth rates compared with that of viruses with seasonal RNP complex ( Figure 2B ). On the other hand, the growth rate of the virus with PB2 141 /PB1 pdm /PA pdm /NP pdm was much lower than that of the virus containing pandemic RNP ( Figure 2C ).
Altered Pathogenicity in Mice Infected With Different Reassortants
It seems that the changes of RNP activities ( Figure 1) were not reflected in viral growth in cell culture (Figure 2 ). However, we were curious as to whether there was any pathogenic change in mice. Therefore, the virulence of these recombinant viruses in mice was determined. To determine LD 50 , 6-week-old female BALB/c mice were challenged with these viruses with different combinations of RNP genes. Mice were infected intranasally with serial 10-fold dilutions of viruses, and the survival rates were monitored daily for 2 weeks (Figure 3) . The LD 50 for the virus containing all seasonal H1N1-RNP was 130 PFU (Table 1) (Table 1) . We also observed that loss of body weight in mice infected with PA pdm containing reassortant virus was more than that of mice infected with other recombinant viruses (data not shown).
To confirm that PA derived from the pandemic strain may increase the virulence of seasonal virus (the combination of PB2 141 /PB1 141 /PA pdm /NP 141 ), we used another mice system for the experiment. Eight-week-old C57BL/6 mice were intranasally inoculated with 200 PFU of viruses, and the mice were sacrificed on day 3 post infection. The virus titers in different organs were assayed by plaque assay. As Figure 4A shows, viral titers in lung homogenates of mice infected with the recombinant virus containing PB2 141 /PB1 141 /PA pdm /NP 141 were significantly higher than that of mice infected with other recombinant viruses. Virus particles in the spleen of mice infected with the PB2 141 /PB1 141 /PA pdm /NP 141 recombinant virus were also detected ( Figure 4B ). To compare the pathogenicity of these reassorted viruses in vivo, a histological analysis of the lungs was performed on mice infected with different recombinant viruses at 3 days following infection. In mock-infected mice, H&E staining of lung sections displayed thin alveolar walls and large air spaces. An inflammation with cellular infiltration in alveolar interstitial spaces and the area surrounding the bronchioles was observed in the mice infected with those recombinant influenza A viruses. Consistent with the results shown in Table 1 , increased cellular infiltration and hemorrhage was found in the lungs of mice infected with the virus containing PB2 141 /PB1 141 /PA pdm /NP 141 . Notably, all lung tissues from infected mice (n 6 for each group, 2 independent experiments were performed) exhibited the same result as that of the PA reassortant virus (PB2 141 /PB1 141 /PA pdm /NP 141 )-excessive infiltration and hemorrhage ( Figure 4C ). into a postpandemic period worldwide. Localized outbreaks of varying magnitudes are expected to show significant levels of H1N1 transmission similar to the behavior of a seasonal influenza virus. As a result, this new H1N1 strain is likely to cocirculate with existing seasonal influenza viruses, and new pathogenic strains may emerge by reassortment. This study focuses on the reassortment of RNP genes and their impact on viral replication and the change in virulence in an animal model. Our findings suggest that the RNP activities of seasonal H1N1 virus decreased when its PB2 gene was replaced by the PB2 from H1N1 pdm . In contrast, the PA, PB1, and NP genes of H1N1 pdm increased the RNP activity of seasonal H1N1 when Figure 2 . Generation of recombinant viruses with different RNP combinations and growth kinetics of rescued viruses. A, Recombinant viruses with different RNP gene combinations were generated by reverse genetics. Genes derived from seasonal H1N1 are shown in dark gray and those from pandemic H1N1 are indicated by light gray. For biosafety, the rest of the genes for generating a recombinant virus, including HA, NA, M, and NS, were derived from the PR8 strain (slash). The growth rates of recombinant viruses indicated in the upper panel (B ) and lower panel (C ) were compared respectively. A549 cells were infected with the indicated viruses at an MOI of 0.001 and cultured at 37°C in the presence of trypsin at 1 lg/mL. Cultured supernatants were harvested at the indicated times (12, 24, 36, 48, 60 , and 72 hours), and virus titers were determined by plaque assay in MDCK cells. Geometric mean titers and SD were calculated from 2 independent experiments. MOI, multiplicity of infection.
DISCUSSION
introduced into the genome of the seasonal virus. Previous studies showed that both the PB2 and PA genes of H1N1 pdm originated from the North American avian virus. These studies also showed that these genes were introduced into the swine population around 1998 and that PB1 recently evolved from a human seasonal H3N2 around the same time. Regardless of whether both H1N1 pdm PB2 and PA originated from the North American avian virus, they exhibited contrary RNP activity when reassorted into human seasonal virus.
Comparing the identity of RNP sequences between 2 influenza A viruses, the protein sequences of the 2 strains in this work have a high level of identity for the PB1 gene. Sequence identities between the 2 PA genes were also high, which is comparable to the identities between the 2 PB2 genes (92.7%-94.0%). The sequence identities for each polymerase subunit among different strains are high, despite the fact that they manifested contrary RNP activity levels. Interestingly, NP protein sequences were less similar in these 2 strains (89.3%-92.3%). Our previous analysis also found that NP is the gene that can clearly distinguish avian from human influenza A viruses [25, 26] .
The decreases of RNP activity in seasonal H1N1 influenza A viruses caused by PB2 from H1N1 pdm can be explained by several factors. Similar decreased RNP activity in seasonal H3N2 influenza A viruses resulting from pandemic PB2 was also observed (data not shown). We hypothesize that one possibility might be the lack of a known virulence factor from H1N1 pdm PB2. PB2 has been shown to be an important determinant of virulence for H5N1, H7N7, and the 1918 virus. This has been traced to its amino acid, E627K, at position 627, which is a signature associated with host restriction [20, [27] [28] [29] [30] as well as viral virulence [30] [31] [32] [33] [34] . Avian-like signature E was found at this position in the PB2 of H1N1 pdm . However, the mutation from E to the human-like signature K did not change the virulence of the virus or affect its transmission in ferrets [16, 17] , even though the mutation enhanced polymerase complex-driven reporter gene expression in vitro.
Because of these findings, we speculate that other unidentified positions exist in PB2 that are important for virulence. Herfst et al. [35] examined the effects of D701N and E677G on the virulence change in H1N1 pdm and found no enhancement of its virulence. Lastly, the importance of position 591 in PB2 for efficient replication of the pandemic H1N1 viruses in humans has been reported [36, 37] . Another study has found that PB2 residue 271 enhances mammalian adaption. The 2009 pandemic H1N1 virus contains the human-like residue at 271 of PB2, and a decreased polymerase activity was found when it was mutated back to avian-like signature [38] .
Recent surveillance data show that seasonal influenza viruses and H1N1 pdm are cocirculating [39] , which raises the possibility of coinfection and reassortment. Because of the biosafety regulation in Taiwan, we used HA, NA, M, and NS gene segments from a laboratory strain PR8 for generation of recombinant viruses, which definitely would limit our conclusions because different results could have been obtained if we had used homologous gene segments from H1N1 pdm and seasonal viruses. The nonhomologous combinations also restricted our study. We could have rescued the virus containing 4 RNP genes from seasonal H3N2 virus and the rest of the genes (HA, NA, M, and NS) from PR8. The recombinant viruses, however, were not rescued when any RNP gene in this backbone (PB2 3446 / PB1 3446 /PA 3446 /NP 3446 1 HA PR8 /NA PR8 /M PR8 /NS PR8 ) was replaced by a corresponding one from H1N1 pdm .
Fortunately, the recombinant viruses with the replacement of any RNP gene from H1N1 pdm into the backbone of PB2 141 / PB1 141 /PA 141 /NP 141 1 HA PR8 /NA PR8 /M PR8 /NS PR8 could be rescued, which led us to find that PA derived from H1N1 pdm increases the pathogenicity of seasonal H1N1 in mice. Unlike the highly pathogenic avian H5N1 viruses, seasonal H1N1 displays relatively mild pathogenicity. Our results, however, demonstrate that a seasonal H1N1 may change its virulence when acquiring a single RNP gene from H1N1 pdm . In particular, our data suggest that PA gene reassortment enhanced the lung virus titer and caused more evident cell infiltration into the lung.
Although a virus can increase its pathogenicity by acquiring genes from other highly pathogenic viruses (such as happened with the H5N1 avian flu virus), we show that reassortment between 2 relatively mild strains could also boost virulence. Our findings suggest that a seasonal influenza A virus may have its virulence altered when it receives PA from H1N1 pdm . It has be reported recently that pandemic H1N1 virus containing PB2 or together with PA from seasonal H1N1 virus were attenuated in ferrets l [40] . Their work, to some extent, supports our finding that PA may serve as a novel virulence factor for H1N1 pdm . Moreover, Octaviani et al. [41] utilized reverse genetics to produce reassortants between seasonal and pandemic H1N1 viruses and found that some recombinant viruses with mixed gene segments had higher viral growth rates compared with that of their parental strains in a cell culture system. Taken together, these studies highlight the importance of continuous monitoring of virulence changes in the seasonal influenza viruses for possible reassortants between the seasonal viruses and H1N1 pdm or other highly pathogenic influenza viruses. 
